Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 03-2014 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 116 | 46 | 20 | 58 | 58 |
| Accounts receivable | 13 | 0 | -43 | -3 | 11 |
| Accounts payable and accrued liabilities | 164 | 98 | N/A | N/A | N/A |
| Other Working Capital | 116 | -23 | -12 | 26 | 51 |
| Other Operating Activity | -2,458 | -2,400 | -1,221 | -154 | -135 |
| Operating Cash Flow | $-2,048 | $-2,278 | $-1,255 | $-73 | $-15 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -182 | -312 | -219 | N/A | N/A |
| Purchase Sale Intangibles | -62 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 100 | -100 |
| Investing Cash Flow | $-244 | $-312 | $-219 | $100 | $-100 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,366 | 953 | -8 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | 0 | -195 |
| Common Stock Issued | 3,836 | N/A | 3,186 | N/A | N/A |
| Other Financing Activity | 225 | 0 | 15 | 0 | 0 |
| Financing Cash Flow | $5,427 | $953 | $3,193 | $0 | $-195 |
| Beginning Cash Position | 82 | 1,719 | 0 | 111 | 421 |
| End Cash Position | 3,217 | 82 | 1,719 | 138 | 111 |
| Net Cash Flow | $3,135 | $-1,637 | $1,719 | $27 | $-311 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,048 | -2,278 | -1,255 | -73 | -15 |
| Capital Expenditure | -245 | -312 | -219 | N/A | 0 |
| Free Cash Flow | -2,293 | -2,590 | -1,474 | -73 | -16 |